43742-1493 NDC - BIO CYTOTOX PHASE (PODOPHYLLUM PELTATUM, ASCORBICUM ACIDUM, GALIUM APARINE, HYDRASTIS CANADENSIS, NICOTINAMIDUM, PYRIDOXINUM HYDROCHLORICUM, RIBOFLAVINUM, SARCOLACTICUM ACIDUM, THIAMINUM HYDROCHLORICUM, ALPHA-LIPOICUM ACIDUM, COLCHICUM AUTUMNALE, CONIUM MACULATUM, NATRUM OXALACETICUM, SULPHUR, VACCINIUM MYRTILLUS, NOREPINEPHRINE, ACETYLSALICYLICUM ACIDUM, ADENOSINUM TRIPHOSPHORICUM DINATRUM, ANTHRACHINONUM, HISTAMINUM HYDROCHLORICUM, MAGNESIUM GLUCONICUM DIHYDRICUM, NADIDUM, NAPHTHOCHINONUM, PANTOTHENIC ACID, UBIDECARENONUM,)

Drug Information

Product NDC: 43742-1493
Proprietary Name: Bio Cytotox Phase
Non Proprietary Name: Podophyllum Peltatum, Ascorbicum Acidum, Galium Aparine, Hydrastis Canadensis, Nicotinamidum, Pyridoxinum Hydrochloricum, Riboflavinum, Sarcolacticum Acidum, Thiaminum Hydrochloricum, alpha-Lipoicum Acidum, Colchicum Autumnale, Conium Maculatum, Natrum Oxalaceticum, Sulphur, Vaccinium Myrtillus, Norepinephrine, Acetylsalicylicum Acidum, Adenosinum Triphosphoricum Dinatrum, Anthrachinonum, Histaminum Hydrochloricum, Magnesium Gluconicum Dihydricum, Nadidum, Naphthochinonum, Pantothenic Acid, Ubidecarenonum,
Active Ingredient(s): 10 [hp_X]/mL ADENOSINE TRIPHOSPHATE DISODIUM; 10 [hp_X]/mL ANTHRAQUINONE; 6 [hp_X]/mL ASCORBIC ACID; 10 [hp_X]/mL ASPIRIN; 8 [hp_X]/mL BILBERRY; 8 [hp_X]/mL COLCHICUM AUTUMNALE BULB; 8 [hp_X]/mL CONIUM MACULATUM FLOWERING TOP; 6 [hp_X]/mL GALIUM APARINE; 6 [hp_X]/mL GOLDENSEAL; 10 [hp_X]/mL HISTAMINE DIHYDROCHLORIDE; 3 [hp_C]/mL HYDROQUINONE; 6 [hp_X]/mL LACTIC ACID, L-; 10 [hp_X]/mL MAGNESIUM GLUCONATE; 15 [hp_X]/mL MANGANESE PHOSPHATE, DIBASIC; 10 [hp_X]/mL NADIDE; 10 [hp_X]/mL NAPHTHOQUINE; 6 [hp_X]/mL NIACINAMIDE; 10 [hp_X]/mL NOREPINEPHRINE BITARTRATE; 10 [hp_X]/mL PANTOTHENIC ACID; 5 [hp_X]/mL PODOPHYLLUM; 6 [hp_X]/mL PYRIDOXINE HYDROCHLORIDE; 6 [hp_X]/mL RIBOFLAVIN; 30 [hp_C]/mL SALMONELLA ENTERICA SUBSP. ENTERICA SEROVAR ENTERITIDIS; 8 [hp_X]/mL SODIUM DIETHYL OXALACETATE; 8 [hp_X]/mL SULFUR; 6 [hp_X]/mL THIAMINE HYDROCHLORIDE; 8 [hp_X]/mL THIOCTIC ACID; 10 [hp_X]/mL UBIDECARENONE
Administration Route(s): ORAL
Dosage Form(s): LIQUID
Pharmacy Class(es): Analogs/Derivatives [Chemical/Ingredient]; Anti-Inflammatory Agents; Non-Steroidal [CS]; Ascorbic Acid [CS]; Calculi Dissolution Agent [EPC]; Catecholamine [EPC]; Catecholamines [CS]; Cyclooxygenase Inhibitors [MoA]; Decreased Platelet Aggregation [PE]; Decreased Prostaglandin Production [PE]; Depigmenting Activity [PE]; Increased Large Intestinal Motility [PE]; Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]; Inhibition Small Intestine Fluid/Electrolyte Absorption [PE]; Magnesium Ion Exchange Activity [MoA]; Magnetic Resonance Contrast Activity [MoA]; Melanin Synthesis Inhibitor [EPC]; Melanin Synthesis Inhibitors [MoA]; Nonsteroidal Anti-inflammatory Drug [EPC]; Osmotic Activity [MoA]; Osmotic Laxative [EPC]; Paramagnetic Contrast Agent [EPC]; Platelet Aggregation Inhibitor [EPC]; Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]; Vitamin B 6 [Chemical/Ingredient]; Vitamin B6 Analog [EPC]; Vitamin C [EPC]

Labeler Information

Field Name	Field Value
Labeler Name:	Deseret Biologicals, Inc.
Product Type:	HUMAN OTC DRUG
FDA Application Number:
Marketing Category:	UNAPPROVED HOMEOPATHIC
Start Marketing Date:	7/9/2019

Package Information

No.	Package Code	Package Description	Billing Unit
1	43742-1493-1	30 mL in 1 BOTTLE, DROPPER (43742-1493-1)

NDC Record

Field Name	Field Value	Definition
PRODUCT NDC	43742-1493	The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
PRODUCT TYPE NAME	HUMAN OTC DRUG	Indicates the type of product, such as Human Prescription Drug or Human Over the Counter Drug. This data element matches the “Document Type” field of the Structured Product Listing.
PROPRIETARY NAME	Bio Cytotox Phase	The proprietary name also known as the trade name is the name of the product chosen by the medication labeler for marketing purposes.
NON PROPRIETARY NAME	Podophyllum Peltatum, Ascorbicum Acidum, Galium Aparine, Hydrastis Canadensis, Nicotinamidum, Pyridoxinum Hydrochloricum, Riboflavinum, Sarcolacticum Acidum, Thiaminum Hydrochloricum, alpha-Lipoicum Acidum, Colchicum Autumnale, Conium Maculatum, Natrum Oxalaceticum, Sulphur, Vaccinium Myrtillus, Norepinephrine, Acetylsalicylicum Acidum, Adenosinum Triphosphoricum Dinatrum, Anthrachinonum, Histaminum Hydrochloricum, Magnesium Gluconicum Dihydricum, Nadidum, Naphthochinonum, Pantothenic Acid, Ubidecarenonum,	The non-proprietary name is sometimes called the generic name. The generic name usually includes the active ingredient(s) of the product.
DOSAGE FORM NAME	LIQUID	The translation of the dosage form Code submitted by the firm.
ROUTE NAME	ORAL	The translation of the route code submitted by the firm, indicating route of administration.
START MARKETING DATE	7/9/2019	This is the date that the labeler indicates was the start of its marketing of the drug product.
MARKETING CATEGORY NAME	UNAPPROVED HOMEOPATHIC	Product types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
LABELER NAME	Deseret Biologicals, Inc.	Name of Company corresponding to the labeler code segment of the Product NDC.
SUBSTANCE NAME	ADENOSINE TRIPHOSPHATE DISODIUM; ANTHRAQUINONE; ASCORBIC ACID; ASPIRIN; BILBERRY; COLCHICUM AUTUMNALE BULB; CONIUM MACULATUM FLOWERING TOP; GALIUM APARINE; GOLDENSEAL; HISTAMINE DIHYDROCHLORIDE; HYDROQUINONE; LACTIC ACID, L-; MAGNESIUM GLUCONATE; MANGANESE PHOSPHATE, DIBASIC; NADIDE; NAPHTHOQUINE; NIACINAMIDE; NOREPINEPHRINE BITARTRATE; PANTOTHENIC ACID; PODOPHYLLUM; PYRIDOXINE HYDROCHLORIDE; RIBOFLAVIN; SALMONELLA ENTERICA SUBSP. ENTERICA SEROVAR ENTERITIDIS; SODIUM DIETHYL OXALACETATE; SULFUR; THIAMINE HYDROCHLORIDE; THIOCTIC ACID; UBIDECARENONE	An active ingredient is the substance responsible for the medicinal effects of a product specified by the substance's molecular structure or if the molecular structure is not known, defined by an unambiguous definition that identifies the substance. Each active ingredient name is the preferred term of the UNII code submitted.
ACTIVE NUMERATOR STRENGTH	10; 10; 6; 10; 8; 8; 8; 6; 6; 10; 3; 6; 10; 15; 10; 10; 6; 10; 10; 5; 6; 6; 30; 8; 8; 6; 8; 10
ACTIVE INGRED UNIT	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL
PHARM CLASSES	Analogs/Derivatives [Chemical/Ingredient], Anti-Inflammatory Agents, Non-Steroidal [CS], Ascorbic Acid [CS], Calculi Dissolution Agent [EPC], Catecholamine [EPC], Catecholamines [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Depigmenting Activity [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Magnetic Resonance Contrast Activity [MoA], Melanin Synthesis Inhibitor [EPC], Melanin Synthesis Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC], Osmotic Activity [MoA], Osmotic Laxative [EPC], Paramagnetic Contrast Agent [EPC], Platelet Aggregation Inhibitor [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE], Vitamin B 6 [Chemical/Ingredient], Vitamin B6 Analog [EPC], Vitamin C [EPC]

Drug Information

Labeler Information

Package Information

NDC Record

Download Record